Literature DB >> 20567586

Advantages in IBD: Current Developments in the Treatment of Inflammatory Bowel Diseases.

.   

Abstract

Year:  2010        PMID： 20567586      PMCID： PMC2886486     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

1.  Clinical guidelines for the medical management of left-sided ulcerative colitis and ulcerative proctitis: summary statement.

Authors:  Miguel Regueiro; Edward V Loftus; A Hillary Steinhart; Russell D Cohen
Journal:  Inflamm Bowel Dis       Date:  2006-10       Impact factor: 5.325

2.  Medical management of left-sided ulcerative colitis and ulcerative proctitis: critical evaluation of therapeutic trials.

Authors:  Miguel Regueiro; Edward V Loftus; A Hillary Steinhart; Russell D Cohen
Journal:  Inflamm Bowel Dis       Date:  2006-10       Impact factor: 5.325

3.  Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitis.

Authors:  S Hanauer; L I Good; M W Goodman; R J Pizinger; W B Strum; C Lyss; G Haber; C N Williams; M Robinson
Journal:  Am J Gastroenterol       Date:  2000-07       Impact factor: 10.864

4.  A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.

Authors:  R D Cohen; D M Woseth; R A Thisted; S B Hanauer
Journal:  Am J Gastroenterol       Date:  2000-05       Impact factor: 10.864

5.  Long-term use of mesalamine enemas to induce remission in ulcerative colitis.

Authors:  W L Biddle; P B Miner
Journal:  Gastroenterology       Date:  1990-07       Impact factor: 22.682
  5 in total
  6 in total

1.  Local enema treatment to inhibit FOLH1/GCPII as a novel therapy for inflammatory bowel disease.

Authors:  Abhijit A Date; Rana Rais; Taarika Babu; Jairo Ortiz; Pranjali Kanvinde; Ajit G Thomas; Sarah C Zimmermann; Alexandra J Gadiano; Gilad Halpert; Barbara S Slusher; Laura M Ensign
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

2.  Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease.

Authors:  Abhijit A Date; Gilad Halpert; Taarika Babu; Jairo Ortiz; Pranjali Kanvinde; Peter Dimitrion; Janani Narayan; Hannah Zierden; Kalpana Betageri; Olivia Musmanno; Helen Wiegand; Xinglu Huang; Sanjeev Gumber; Justin Hanes; Laura M Ensign
Journal:  Biomaterials       Date:  2018-09-07       Impact factor: 12.479

Review 3.  Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Inflammatory Bowel Disease.

Authors:  Luc J J Derijks; Dennis R Wong; Daniel W Hommes; Adriaan A van Bodegraven
Journal:  Clin Pharmacokinet       Date:  2018-09       Impact factor: 6.447

4.  A Thermo-Sensitive Delivery Platform for Topical Administration of Inflammatory Bowel Disease Therapies.

Authors:  Sidhartha R Sinha; Linh P Nguyen; Mohammed Inayathullah; Andrey Malkovskiy; Frezghi Habte; Jayakumar Rajadas; Aida Habtezion
Journal:  Gastroenterology       Date:  2015-04-08       Impact factor: 22.682

Review 5.  Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient management.

Authors:  Pegah Hosseini-Carroll; Monica Mutyala; Abhishek Seth; Shaheen Nageeb; Demiana Soliman; Moheb Boktor; Ankur Sheth; Jonathon Chapman; James Morris; Paul Jordan; Kenneth Manas; Felix Becker; Jonathan Steven Alexander
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

Review 6.  Oral Delivery of Biologics in Inflammatory Bowel Disease Treatment.

Authors:  Wunan Zhang; Cecilia Bohns Michalowski; Ana Beloqui
Journal:  Front Bioeng Biotechnol       Date:  2021-06-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.